Atlas Trials

Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE

Clinical trial NCT01984788 · COMPLETED

Trial details

NCT number
NCT01984788
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hereditary Angioedema
Start date
2013-11-01
Primary completion
2014-05-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.